BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22555039)

  • 1. Comparison of the epidemiologic features and patterns of initial care for prostate cancer between public and private institutions: a survey by the Brazilian Society of Urology.
    Nardi AC; Reis RB; Zequi Sde C; Nardozza A
    Int Braz J Urol; 2012; 38(2):155-64; discussion 164-6. PubMed ID: 22555039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in treatment choices for localised prostate cancer diagnosed in private and public health services.
    Te Marvelde L; Milne RL; Hornby CJ; Chapman AB; Giles GG; Haines IE
    Med J Aust; 2020 Nov; 213(9):411-417. PubMed ID: 32996611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urologists' personal feelings on PSA screening and prostate cancer treatment.
    Wenzler DL; Rosenberg BH
    J Eval Clin Pract; 2014 Aug; 20(4):408-10. PubMed ID: 24798149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician's sociodemographic profile and distribution across public and private health care: an insight into physicians' dual practice in Brazil.
    Miotto BA; Guilloux AGA; Cassenote AJF; Mainardi GM; Russo G; Scheffer MC
    BMC Health Serv Res; 2018 Apr; 18(1):299. PubMed ID: 29688856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey.
    Surcel CI; Sooriakumaran P; Briganti A; De Visschere PJ; Fütterer JJ; Ghadjar P; Isbarn H; Ost P; Ploussard G; van den Bergh RC; van Oort IM; Yossepowitch O; Sedelaar JP; Giannarini G; ;
    BJU Int; 2015 Apr; 115(4):571-9. PubMed ID: 24802335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.
    Ariane MM; Ploussard G; Rebillard X; Malavaud B; Rischmann P; Hennequin C; Mongiat-Artus P
    World J Urol; 2015 Nov; 33(11):1741-7. PubMed ID: 25822706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of practice integration between urologists and radiation oncologists on prostate cancer treatment patterns.
    Bekelman JE; Suneja G; Guzzo T; Pollack CE; Armstrong K; Epstein AJ
    J Urol; 2013 Jul; 190(1):97-101. PubMed ID: 23399652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early diagnosis of prostate cancer in the Western Cape.
    Heyns CF; Naudé AM; Visser AJ; Marais DC; Stopforth HB; Nyarko JK; Stellmacher GA
    S Afr Med J; 2001 Aug; 91(8):679-84. PubMed ID: 11584784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
    Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
    BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
    Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
    J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry.
    Weerakoon M; Papa N; Lawrentschuk N; Evans S; Millar J; Frydenberg M; Bolton D; Murphy DG
    BJU Int; 2015 Apr; 115 Suppl 5():50-6. PubMed ID: 25601201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Pathologic Upgrading or Locally Advanced Disease in Early Prostate Cancer Patients Based on Biopsy Gleason Score and PSA: A Population-Based Study of Modern Patients.
    Caster JM; Falchook AD; Hendrix LH; Chen RC
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):244-51. PubMed ID: 25841621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The age of the urologist affects the postoperative care of prostate carcinoma patients.
    Tsai DY; Virgo KS; Colberg JW; Ornstein DK; Johnson ET; Chan D; Johnson FE
    Cancer; 1999 Oct; 86(7):1314-21. PubMed ID: 10506719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the 2012 United States Preventive Services Task Force statement on prostate-specific antigen screening: analysis of urologic and primary care practices.
    Perez TY; Danzig MR; Ghandour RA; Badani KK; Benson MC; McKiernan JM
    Urology; 2015 Jan; 85(1):85-9. PubMed ID: 25440819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Observational survey of the French Urological Association evaluating intermittent hormonal modalities treatment in prostate cancer in France].
    Salomon L; Ploussard G; Coloby P; Kouri G; Lebret T; Méjean A; Prunet D; Soulié M
    Prog Urol; 2014 May; 24(6):367-73. PubMed ID: 24821560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of men on active surveillance for low-risk prostate cancer at a safety-net hospital.
    Osterberg EC; Palmer NRA; Harris CR; Murphy GP; Blaschko SD; Chu C; Allen IE; Cooperberg MR; Carroll PR; Breyer BN
    Urol Oncol; 2017 Nov; 35(11):663.e9-663.e14. PubMed ID: 28826701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic characteristics of renal cell carcinoma in Brazil.
    Nardi AC; Zequi Sde C; Clark OA; Almeida JC; Glina S
    Int Braz J Urol; 2010; 36(2):151-7; discussion 158. PubMed ID: 20450499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
    Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
    J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.